Search results
Author(s):
Marianna Fontana
Added:
1 year ago
ESC HF 25 - A study investigating CRISPR gene editing with nexiguran ziclumeran in ATTR cardiomyopathy demonstrated favourable safety and tolerability, with consistent reductions in serum TTR in both wild-type and variant disease.Prof Marianna Fontana (University College London, UK) joins us to discuss the key findings from a two-part, open-label, phase 1 study investigating the treatment effect,…
View more
Author(s):
Milind Y Desai
Added:
1 year ago
ACC 2025 - First-in-human results from MyPEAK-1 show Tn-201 treatment in adults with Mybpc3-associated hypertropic cardiomyopathy was feasible and safe.Dr Milind Desai (Cleveland Clinic, Ohio, US) joins us onsite at ACC 2025 to discuss phase Ib/2a results from the first-in-human, non-randomized study investigating the safety and early efficacy of Tn-201, an adeno-associated virus serotype 9 gene…
View more
MicroRNAs for Cardiac Regeneration
Author(s):
Camilla Olianti
,
Mauro Giacca
Added:
8 months ago
Review Article
Robert Eckel
Job title: Professor of Medicine
Author
Genetics in Hypertrophic Cardiomyopathy
Author(s):
María Noël Brögger
,
Ivonne Johana Cárdenas Reyes
,
Soledad García Hernández
,
et al
Added:
3 months ago
Review Article
The Leap Year Gene of Kit McKinley
Added:
1 year ago
Podcast Episode
Author(s):
Moza A Alzaabi
,
Amin Abdelsalam
,
Majid Alhammadi
,
et al
Added:
2 years ago
Author(s):
Dominic Marcel Alfonso
Added:
3 months ago
Shaun R Opie
Job title: Medical Scientist, Department of Gene and Cell Research
Author
